company background image
93M1

MPH Health Care DB:93M1 Stock Report

Last Price

€20.60

Market Cap

€88.2m

7D

2.0%

1Y

-21.1%

Updated

18 May, 2022

Data

Company Financials +
93M1 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

93M1 Stock Overview

MPH Health Care AG, an investment company engages in the healthcare business in Germany.

MPH Health Care Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for MPH Health Care
Historical stock prices
Current Share Price€20.60
52 Week High€31.20
52 Week Low€19.65
Beta0.75
1 Month Change-6.79%
3 Month Change-11.59%
1 Year Change-21.07%
3 Year Change-47.32%
5 Year Change-43.65%
Change since IPO-11.29%

Recent News & Updates

Shareholder Returns

93M1DE PharmaceuticalsDE Market
7D2.0%2.2%1.0%
1Y-21.1%13.0%-11.1%

Return vs Industry: 93M1 underperformed the German Pharmaceuticals industry which returned 13.7% over the past year.

Return vs Market: 93M1 underperformed the German Market which returned -11.4% over the past year.

Price Volatility

Is 93M1's price volatile compared to industry and market?
93M1 volatility
93M1 Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement6.4%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market3.5%

Stable Share Price: 93M1 is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 93M1's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/aPatrick Brenskehttps://www.mph-ag.de

MPH Health Care AG, an investment company engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology.

MPH Health Care Fundamentals Summary

How do MPH Health Care's earnings and revenue compare to its market cap?
93M1 fundamental statistics
Market Cap€88.20m
Earnings (TTM)-€14.27m
Revenue (TTM)€22.03m

4.0x

P/S Ratio

-6.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
93M1 income statement (TTM)
Revenue€22.03m
Cost of Revenue€0
Gross Profit€22.03m
Other Expenses€36.29m
Earnings-€14.27m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

May 24, 2022

Earnings per share (EPS)-3.33
Gross Margin100.00%
Net Profit Margin-64.76%
Debt/Equity Ratio1.3%

How did 93M1 perform over the long term?

See historical performance and comparison

Valuation

Is MPH Health Care undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 93M1 (€20.6) is trading below our estimate of fair value (€71.49)

Significantly Below Fair Value: 93M1 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 93M1 is unprofitable, so we can't compare its PE Ratio to the German Pharmaceuticals industry average.

PE vs Market: 93M1 is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 93M1's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 93M1 is good value based on its PB Ratio (0.4x) compared to the DE Pharmaceuticals industry average (2.7x).


Future Growth

How is MPH Health Care forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


94.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 93M1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.05%).

Earnings vs Market: 93M1 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 93M1's is expected to become profitable in the next 3 years.

Revenue vs Market: 93M1's revenue (39.4% per year) is forecast to grow faster than the German market (4.8% per year).

High Growth Revenue: 93M1's revenue (39.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 93M1's Return on Equity is forecast to be high in 3 years time


Past Performance

How has MPH Health Care performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-62.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 93M1 is currently unprofitable.

Growing Profit Margin: 93M1 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 93M1 is unprofitable, and losses have increased over the past 5 years at a rate of 62.4% per year.

Accelerating Growth: Unable to compare 93M1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 93M1 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (15.1%).


Return on Equity

High ROE: 93M1 has a negative Return on Equity (-6.35%), as it is currently unprofitable.


Financial Health

How is MPH Health Care's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 93M1's short term assets (€3.3M) exceed its short term liabilities (€1.5M).

Long Term Liabilities: 93M1's short term assets (€3.3M) do not cover its long term liabilities (€5.0M).


Debt to Equity History and Analysis

Debt Level: 93M1 has more cash than its total debt.

Reducing Debt: 93M1's debt to equity ratio has reduced from 4.6% to 1.3% over the past 5 years.

Debt Coverage: 93M1's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 93M1's interest payments on its debt are well covered by EBIT (90.6x coverage).


Balance Sheet


Dividend

What is MPH Health Care current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


7.96%

Forecast Dividend Yield

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 93M1's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 93M1's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 93M1's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 93M1's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: 93M1 is not paying a notable dividend for the German market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 93M1 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Patrick Brenske

13.33yrs

Tenure

Mr. Patrick Brenske has been Chief Executive Officer of MPH Health Care AG (formerly known as MPH Mittelständische Pharma Holding AG) since January 23, 2009 and has been its Member of Management Board sinc...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

MPH Health Care AG's employee growth, exchange listings and data sources


Key Information

  • Name: MPH Health Care AG
  • Ticker: 93M1
  • Exchange: DB
  • Founded: 2008
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: €88.197m
  • Shares outstanding: 4.28m
  • Website: https://www.mph-ag.de

Number of Employees


Location

  • MPH Health Care AG
  • Grünauer Straße 5
  • Berlin
  • Berlin
  • 12557
  • Germany

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/18 00:00
End of Day Share Price2022/05/18 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.